Momenta Pharmaceuticals to present data on M402 drug candidate at 101st AACR meeting

Download PDF Copy

Apr 15 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101^st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.

The following two posters will be presented:

"M402 - A Novel Heparin Sulfate Mimetic Synergizes with Gemcitabine to Improve Survival and Reduce Metastasis and Epithelial-to-Mesenchymal Transition (EMT) in a Genetically Engineered Mouse Model for Pancreatic Cancer" (abstract #LB-43)

-- Poster Session: Sunday, April 18, 2010 from 2:00 PM - 5:00 PM

"M402 - A Novel Heparan Sulfate Proteoglycan Mimetic Targeting Tumor-Host Interactions" (abstract #2269)

-- Poster Session: Monday, April 19, 2010 from 2:00 PM - 5:00 PM

Source Momenta Pharmaceuticals, Inc.

Posted in: Drug Trial News | Medical Condition News

Tags: Biotechnology, Cancer, Drugs, Gemcitabine, Genetic Engineering, Heparin, Metastasis, Mouse Model, Pancreatic Cancer, Pharmaceuticals, Preclinical, Proteoglycan, Research, Tumor

Comments (0)

Download PDF Copy

Suggested Reading

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

New study reveals complex attitudes toward psychedelic therapy

New study reveals complex attitudes toward psychedelic therapy

Danish studies find increased risk of optic nerve damage with diabetes medicine

Danish studies find increased risk of optic nerve damage with diabetes medicine

U.S. wastewater treatment fails to address rising organofluorine contamination

U.S. wastewater treatment fails to address rising organofluorine contamination

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Aging reduces cancer risk by limiting cell regeneration

Aging reduces cancer risk by limiting cell regeneration

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

Study reveals how fatty liver disease leads to liver cancer

Study reveals how fatty liver disease leads to liver cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Psilocybin shows potential for treating mental health disorders in people with cancer and addiction